A scientific team supported in part by the National Institutes of Health (NIH) has developed a new, ultra-high-resolution ...

Antonella Favit-Van Pelt, MD, PhD, discusses the use of neuromodulation and neuroplasticity for addressing gait deficits in patients with multiple sclerosis.

Multiple sclerosis (MS) is a chronic inflammatory disorder that is thought to impact about 2.3 million people around the world. This disorder is characterized by the loss of a protective neuronal ...

When ocrelizumab became the first FDA-approved treatment for early forms of multiple sclerosis (MS) in 2017, it offered patients immense hope. The long-awaited drug is a monoclonal antibody that ...

A diagnostic model based on delayed post-gadolinium enhancement magnetic resonance imaging improves the accuracy of Meniere disease diagnosis.

In relapsing-remitting multiple sclerosis, activation of the peripheral immune system can lead to focal inflammation within the CNS. Over the past three decades, therapeutic development has been ...

Relapsing Multiple Sclerosis: Navigating Treatment Conundrums This activity is supported by an educational grant from Novartis Pharmaceuticals, Inc.

The quest to mitigate disability progression in multiple sclerosis (MS) has long been hindered by our limited understanding of chronic or smouldering neuroinflammation and its drivers. Recent ...

Navigate meal prep challenges with MS. Discover practical strategies for planning, shopping, adapting cooking methods, and simplifying cleanup to overcome fatigue, cognitive issues, and physical ...

“We will not back down”: Democratic lawmakers refused entry to Manhattan ICE facility Reps. Jerry Nadler and Dan Goldman were refused entry to "observe" an ICE facility ...

President Donald Trump on Tuesday appeared to undermine years of US sanctions on Iran, giving its biggest customer China the green light to carry on buying its oil as he seeks to bolster a ...